Page 575 - Multidisipliner Covid 19
P. 575

COVID-19 Pandemisi ve Kalp-Damar Sistemi


                   62.  Karmpaliotis D, Kirtane AJ, Ruisi CP, Polonsky T, Malhotra A, Talmor
                       D, et al. Diagnostic and prognostic utility of brain natriureticPeptide
                       in subjects admitted to the ICU with hypoxic respiratory failure due
                       to noncardiogenic and cardiogenic pulmonary edema.Chest 2007;
                       131:964–71.
                   63.  Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology
                       of fulminant myocarditis. Herz 2020 Mar 5. [Epub ahead ofprint],
                       doi: 10.1007/s00059-020-04909-z.
                   64.  Luecke T, Pelosi P. Clinical review: Positive end-expiratory pressure
                       and cardiac output. Crit Care 2005;9:607–21.
                   65.  Australia and New Zealand Extracorporeal Membrane Oxygenation
                       (ANZ ECMO) Influenza Investigators, Davies A, Jones D,Bailey M,
                       Beca J, Bellomo R, et al. Extracorporeal Membrane Oxygenation for
                       2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA
                       2009;302:1888–95.
                   66. World Health Organization. Clinical management of severe acute
                       respiratory infection when novel coronavirus (2019-nCoV) infection
                       is suspected—interim guidance. Available at: https://www.who.int/
                       publications-detail/clinical-management-of-severe-acuterespiratory-
                       infection-when-novel-coronavirus-(ncov)-infection-is-suspected.
                       2020.Accessed Mar 24
                   67. Bartlett RH, Ogino MT, Brodie D, McMullan DM, Lorusso R, MacLaren
                       G, et al. Initial ELSO Guidance Document: ECMOfor COVID-19 Pati-
                       ents with Severe Cardiopulmonary Failure. ASAIO J 2020 Mar 30.
                       [Epub ahead of print], doi: 10.1097/MAT.0000000000001173.
                   68.  Australia and New Zealand Extracorporeal Membrane Oxygenation
                       (ANZ ECMO) Influenza Investigators, Davies A, Jones D,Bailey M,
                       Beca J, Bellomo R, et al. Extracorporeal Membrane Oxygenation for
                       2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA
                       2009;302:1888–95.
                   69.  Chatre C, Roubille F, Vernhet H, Jorgensen C, Pers YM. Cardiac Com-
                       plications Attributed to Chloroquine and Hydroxychloroquine:A Sys-
                       tematic Review of the Literature. Drug Saf 2018;41:919–31.
                   70.  Bouferrache K, Vieillard-Baron A. Acute respiratory distress syndrome,
                       mechanical ventilation, and right ventricular function. CurrOpin Crit
                       Care 2011;17:30–5.
                   71.  Repessé X, Charron C, Vieillard-Baron A. Acute cor pulmonale in




                       574
   570   571   572   573   574   575   576   577   578   579   580